Fundraising FoxViraCyte
New Brighton, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into ViraCyte
Each arrow is one introduction. Sign up to fill in the first one.
45 people can intro you to Juan
Ask Farzad Soleimani to introduce you to Juan Vera
You →Farzad · together at Baylor College of Medicine →Juan
Sign up to find every way you can get introduced to ViraCyte
- Your email: who you already know at ViraCyte, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ViraCyte team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
ViraCyte was founded in 2018 by Juan Vera and Malcom Brenner.
JV
Juan VeraCo-founderJuan Vera trained as a medical surgeon and spent 12 years at Baylor College of Medicine's Center for Cell and Gene Therapy developing T cell therapies and manufacturing processes, including work with the G-Rex cell culture platform for large-scale T cell production. He has collaborated with Celgene and Bluebird Bio on CAR T cell therapy development and has experience translating therapeutic candidates from research to clinical manufacturing.
MB
Malcom BrennerCo-founder
DH
David HallalExecutive
VS
Vikas SinhaExecutive
JW
John WilsonNamed on SEC filing
Board
AG
Investors · 1
MPM BioImpactinferredBoston · $1M – $15Mvia Ansbert Gadicke · board
How we know: board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$151.3M disclosed across 2 rounds · 2018–2019
▶$121.3MraisedMay 2019 · 47 investors · BiotechnologyRule 506(b)
▶$121.3MraisedMay 2019 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David HallalExecutive Officer, Director
- Vikas SinhaExecutive Officer, Director
- John WilsonDirector
- Morana Jovan-EmbiricosDirector
- Malcom BrennerDirector
- Ansbert GadickeDirector
- Juan VeraDirector
- Offering amount
- $121.3M
- Amount sold
- $121.3M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$30MraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
▶$30MraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ansbert GadickeDirector
- Juan VeraDirector
- John WilsonDirector
- David HallalExecutive Officer, Director
- Vikas SinhaExecutive Officer, Director
- Malcom BrennerDirector
- Offering amount
- $50M
- Amount sold
- $30M
- Proceeds to insiders
- $6.8M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded ViraCyte?
- ViraCyte was founded by Juan Vera, Malcom Brenner in 2018.
- Who are ViraCyte's investors?
- ViraCyte's investors include MPM BioImpact.
- How much funding has ViraCyte raised?
- ViraCyte has disclosed $151.3M raised across 2 rounds.
- Where is ViraCyte headquartered?
- ViraCyte is headquartered in New Brighton, US.